- H1 antagonist authorized for the symptomatic management of allergic rhinoconjunction and urticaria
- Exhibits elimination half-life of 14.5 hours.
- In allergies rhino conjunction, it shows similar efficacy to desloratadine and cetirizine with respect to symptom relief
- In urticaria, a shows similar efficacy to levocetirizine in the reduction of pruritus
- Well-tolerated and safe to use in geriatric
Uses of Bilastin 20mg + Montelucast 10mg:
- allergic rhinoconjunctivitis
- Chronic urticaria
- Puts a cross on your allergies